Infinity Pharmaceuticals, Inc.
INFI
INFI was delisted on the 13th of September, 2023.
94 hedge funds and large institutions have $52.1M invested in Infinity Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 29 reducing their positions, and 16 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 29
5% less funds holding
Funds holding: 99 → 94 (-5)
15% less capital invested
Capital invested by funds: $61.4M → $52.1M (-$9.39M)
31% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 16
98% less call options, than puts
Call options by funds: $26K | Put options by funds: $1.04M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$3.54M |
| 2 |
Millennium Management
New York
|
+$872K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$330K |
| 4 |
QIM
Quantitative Investment Management
Charlottesville,
Virginia
|
+$201K |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$191K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$3.02M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.9M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$553K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$290K |
| 5 |
Renaissance Technologies
New York
|
-$210K |
INFI Hedge Fund Activity: Q4 2016 in Review
94 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q4 2016, worth a combined $52.1M — down 15% from $61.4M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of INFI and 11 opened new positions — a net loss of 5 holders — while 29 trimmed existing stakes and 31 added.
The largest buyer was BVF Inc, adding an estimated $3.54M. The largest seller was Deerfield Management, exiting entirely with an estimated $3.02M sold.
- 94 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q4 2016, down from 99 in Q3 2016.
- Funds reported $52.1M of Infinity Pharmaceuticals, Inc. stock for Q4 2016, down 15% quarter-over-quarter.
- 11 funds opened new Infinity Pharmaceuticals, Inc. positions in Q4 2016 and 16 closed out, a net change of -5 holders.
- The largest Infinity Pharmaceuticals, Inc. buyer in Q4 2016 was BVF Inc, an estimated $3.54M added.
- The largest Infinity Pharmaceuticals, Inc. seller in Q4 2016 was Deerfield Management, an estimated $3.02M sold.
Based on aggregated 13F filings for Q4 2016.